Services & Solutions.Are you confident that your company is in compliance with government pronouncements set forth in US state and federal law, the U.S. Federal Sentencing Guidelines, the Department of Health and Human Services Office of Inspector General's ("OIG's") Compliance Program Guidance for Pharmaceutical Manufacturers (also applicable to device manufacturers), and other government guidance, industry codes and best practices? If not, we can help you achieve these goals in a manner that takes into account limited resources at your company, including staff, time, budget, or a combination of all three.
|
Compliance OfficerPlace your trust in health care compliance professionals, including attorneys and industry experts that serve as global Chief Compliance Officers. These individuals are experienced in assessing, designing, implementing and managing global healthcare compliance programs. This includes policies/procedures, training, auditing/monitoring, and business strategy and execution.
|
"Sunshine" Spend ReportingOur subject matter experts have supported over 100 clients with global spend transparency disclosure requirements, including the US Open Payments ("Sunshine Act") and French "Loi Bertrand" laws, as well as state and local disclosure laws. Save time and money while ensuring that your government reports are not only accurate and complete, but also vetted by compliance professionals trained at identifying compliance issues.
|
Drug Price and Compliance Reporting
Simplify compliance with disparate U.S. state reporting requirements by leveraging healthcare attorneys responsible for monitoring and managing compliance with current and pending U.S. state reporting requirements covering a variety of areas, including: drug price/cost, product samples, lobbyist and sales representative licensure/registration, and code of conduct certifications.
Rx Price Transparency Tracker
Global Compliance Strategies has supported compliance with US state drug price reporting laws for many pharmaceutical manufacturers since the inception of these complex price transparency requirements. During that time, we have had the opportunity to learn about the needs and challenges of our clients who in turn have helped us design a one-of-a-kind, off-the-shelf, web-based software system to manage price transparency obligations.
Combining legal expertise and cost-effective automation, we are extremely excited to announce the Rx Price Transparency Tracker. This intuitive system enables manufacturers to quickly and easily analyze an unlimited number of prescription drug price increase scenarios in order to instantly identify all state notification requirements. In addition, the system will have an optional upgrade for businesses that want to automatically generate monthly, quarterly, annual and ad hoc price transparency reports and notifications.
Stringent state enforcement has imposed millions of dollars in penalties on manufacturers for failing to timely and/or accurately disclose drug price increases. As a result, Global Compliance Strategies is introducing this platform as manufacturers are planning Q1 drug price increases that may trigger notifications due as early as the beginning of November. For those interested in analyzing and interpreting the labyrinth of proliferating state laws that are implicated, the Rx Price Transparency Tracker can alleviate that burden.
Combining legal expertise and cost-effective automation, we are extremely excited to announce the Rx Price Transparency Tracker. This intuitive system enables manufacturers to quickly and easily analyze an unlimited number of prescription drug price increase scenarios in order to instantly identify all state notification requirements. In addition, the system will have an optional upgrade for businesses that want to automatically generate monthly, quarterly, annual and ad hoc price transparency reports and notifications.
Stringent state enforcement has imposed millions of dollars in penalties on manufacturers for failing to timely and/or accurately disclose drug price increases. As a result, Global Compliance Strategies is introducing this platform as manufacturers are planning Q1 drug price increases that may trigger notifications due as early as the beginning of November. For those interested in analyzing and interpreting the labyrinth of proliferating state laws that are implicated, the Rx Price Transparency Tracker can alleviate that burden.
